Lol shameless cross promotion.
Happy to take the other side of the bet on NEU and did by going short above $8.90 after the NNZ-2591 IND FDA approval at the end of January. From where I'm sitting, NEU looks very overpriced.
Some might think PTX has become over-priced more recently also and while peer comparisons are handy, I still remember when SYC used to put up the slide in his pressos comparing how undervalued PTX was (circa $250m MC) compared to peers. Look how that's tunred out lol
PTX Media related, page-1075
-
- There are more pages in this discussion • 539 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
